PharVision Advisers’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,752
Closed -$465K 313
2024
Q4
$465K Buy
+10,752
New +$465K 0.39% 53